MedPath

Comparing Dexmedetomidine and Propofol infusion as added anesthetic drugs in patients undergoing Trans nasal Trans sphenoidal excision of pituitary tumor surgeries

Not Applicable
Completed
Conditions
Health Condition 1: D3A8- Other benign neuroendocrine tumors
Registration Number
CTRI/2020/07/026811
Lead Sponsor
Amrita Institute of Medical Sciences and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
48
Inclusion Criteria

American Society of Anesthesiologists (ASA) physical status 1 to 2

Age between 18 and 65 years

Scheduled for elective TNTS resection of pituitary tumor.

Exclusion Criteria

Patients with ASA status 3, 4, and 5

Preoperative Glasgow Coma Scale less than 15

Preoperative HR less than 50/min

Patients on Beta Blockers

Heart block of any degree and/or any other cardiac comorbidities

Known allergy to Dexmedetomidine and Propofol

Refusal to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath